Statements Author contributions AN: Writing original draft
Regul Pept 175:2129 Lu N, Sun H, Yu J, Wang X, Liu D, Zhao L, Sun L, Zhao H, Tao B, Liu J (2015) Glucagon-like peptide-1 receptor agonist liraglutide has anabolic bone effects in ovariectomized rats without diabetes
Extending treatment to one year, the gap widens: about 4% greater weight loss in non-diabetics on semaglutide, and about 5.5% greater on tirzepatide. Some researchers suggest that behavioral differences such as motivation, adherence and engagement in lifestyle changes might help explain this gap
Intralesional and topical treatments for Peyronies disease: a narrative review of current knowledge
Cosmetic & Personal Care Formulations Only
The postpartum period involves disrupted sleep, irregular eating patterns, and intense caregiving demands, which is why close monitoring and ongoing check-ins with your care team are especially important when starting a GLP-1 medication